Login to Cosmic account COSMIC account
Assemble your responses (QUESTIONS 1-8) into one PDF ❗ ❗
QUESTION 1
- Go to the Mutational Signatures siteLinks to an external site. and click on “SigProfilerAssignment” → “Get started” → “I acknowledge…”
- Download the file filtered_colo829.vcfDownload filtered_colo829.vcf and rename it to “lastname_firstname_colo829.vcf”
- Upload the renamed VCF file with the following parameters:
input = “Mutation calling file”,- Mutation calling file format = “VCF”,
- reference = “hg19/GRCh37”,
- variant class = “SBS”,
- reference mutational signatures = “COSMIC v3.4”,
- type of study = “Whole-genome”.
Attach a screenshot showing the file name and sample recognized on the COSMIC upload page.
QUESTION 2
Click on the “Samples reconstruction” tab to show the mutation mutational spectrum.
- Download the PNG image.
- Insert the PNG into your document.
QUESTION 3
Copy the signature contributions shown in the spectrum. Report the signatures detected and their proportional contributions exactly as shown (e.g., “SBS4 = 35.74%”).
QUESTION 4
For each detected signature, answer in ≤ 100 words:
- Mutational process/etiology (what causes it?)
- Typical base-substitution pattern (e.g., C>T at CpG; CC>TT)
- Why it is expected / unexpected in melanoma
QUESTION 5
Concept check – Tumour-Suppressor Genes vs. Oncogenes
Explain, in your own words (≤ 150 words total):
- what defines a tumour-suppressor gene (TSG)
- what defines an oncogene
- the key difference in the kinds of mutations that activate each class during cancer development
QUESTION 6
Using the Cancer Gene CensusLinks to an external site. (or NCBI Gene / COSMIC Gene Summary), place each mutated gene below into one of the three categories. Use the table format provided. A single gene may be marked “U” (dual/uncertain) if credible sources disagree.
ATR • BIRC6 • BRAF • CSMD3 • CTNNA2 • DCC • ERBB3 • ERBB4 • GLI1 • MET • MUC16 • PDGFRA • SF3B1 • TNC • TP63
Gene | O = Oncogene | T = Tumour-suppressor | U = Uncertain |
|---|
QUESTION 7
Choose four genes from Q6 (at least one oncogene and one TSG). For each selected gene, provide 2–3 concise bullet points that address:
- Type of mutation observed in COLO-829 and its impact on the protein (gain- or loss-of-function, splice defect, etc.).
- How that altered protein activity contributes to melanoma growth, survival, or metastasis.
- Connection (if any) to UV-induced DNA damage pathways or selection pressures.
QUESTION 8
Insert a brief concluding paragraph (≤ 75 words) summarizing how the dominant UV signatures you observed align with the driver mutations identified in Q7.